Yang Liu, PhD

Founder, Chairman, Chief Executive Officer, and Chief Scientific Officer

Dr. Yang Liu cofounded OncoImmune and led it until its acquisition by Merck. Dr. Liu is recognized internationally for his research on immune recognition of cancer and the activation of lymphocytes, the main immune defender against cancer. He received the Markey Scholar Award in 1992, the Sears Scholar Award in 1993, and the Snyder Award for Cancer Research in 2015 and was elected to the rank of Fellow at the American Association for the Advancement of Science (AAAS) in 2004 for his pioneering contribution to innate immunity, T-cell costimulation, and cancer immunology.

Dr. Liu received his PhD from the Australian National University and completed his postdoctoral fellowship at Yale University. Prior to serving full time as Chief Executive Officer of OncoC4, he was on faculty at multiple academic institutions, including Yale University, New York University, Ohio State University, the Children’s National Medical Center, and the Institute of Human Virology at the University of Maryland School of Medicine.